In addition, we also investigated the effects of Sema4D knockdown on B16-F10R cells in response to nivolumab, downregulation of Sema4D also increased the inhibiting the growth of tumor cells and reducing cell invasion and migration. Here, SEMA4D is linked to neoplasm.